CAR T-Cell Therapy: New Advances Move On Past Setbacks

by admin | Jun 9, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Tiffany Yesavag – Genetic Bioengineering & Biotechnology News – Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target and destroy cancer cells. While the field has sparked...

Stem cell model replicates human amniotic sac development past two weeks

by admin | Jun 6, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by The Francis Crick Institute – Phys.Org – Researchers at the Francis Crick Institute have developed a new stem cell model of the mature human amniotic sac, which replicates development of the tissues supporting the embryo from two to four weeks after...

Infant becomes world’s first patient to undergo personalized gene-editing treatment

by admin | Jun 5, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Jon LaPook – CBS NEWS – Philadelphia — Soon after KJ Muldoon was born in the summer of 2024, he was diagnosed with a rare genetic disorder that is fatal for about half the infants who are born with it. Until now, the only effective long-term treatment...

Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options

by admin | Jun 4, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Nick Paul Taylor – Fierce Biotech – Biotech bank balances were again in focus Monday morning, with Tango Therapeutics cutting preclinical work to stretch its cash runway and Avalo Therapeutics outlining options for preserving its money. Tango extended...

Embryonic macrophages found to control blood stem cell numbers in bone marrow

by admin | Jun 3, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Kerstin Wagner, Leibniz – MedicalXpress.com – Scientists at the Leibniz Institute on Aging—Fritz Lipmann Institute (FLI) in Jena have discovered a previously unknown function of immune cells in the bone marrow. Embryonic macrophages—specialized...

Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration

by admin | Jun 2, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Robert Sanders – UC Berkley News – In a decision released today (May 12), the U. S. Court of Appeals for the Federal Circuit in Washington, D.C., ordered the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) to reconsider its 2022...